You actually gave a far better synopsis of the issues than I probably would have, if you'll forgive me.
That is the heart of it. When we think about consent, it is both an act and a process.
When we look at Canadian support for health system planning and that kind of thing, we are relatively strong, but it's far from 100%. A lot of that comes down to issues of trust and familiarity. Even in the context of an individual consenting to their treatment, there are complexities, and that's where that process piece kicks in.
Often, one of the concerns we hear in the context of our conversations is about making sure there's an appropriate balance between what we ask of the patient from a consent perspective and how much time the clinician is spending with the patient, with the predominant focus of that conversation being about care.
There are a number of process considerations that come with asking for consent in setting up a registry like this. Perhaps from a literature standpoint it may make more sense for the patient notice component of it, like opting in to receive information about your implants and the future of that device relative to health system planning, where the rate—and Juliana can speak far more directly to this—of less than 100% likelihood of consent would impact the quality of the registry that came out of it.